Your browser doesn't support javascript.
loading
Antipsychotics and COVID-19: the debate goes on - Authors' reply.
De Picker, Livia; Mazza, Mario Gennaro; Vai, Benedetta.
Affiliation
  • De Picker L; University Psychiatric Hospital Campus Duffel, 2570 Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium. Electronic address: livia.depicker@uantwerp.be.
  • Mazza MG; Psychiatry & Clinical Psychology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Vai B; Psychiatry & Clinical Psychology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Fondazione Centro San Raffaele, Milan, Italy.
Lancet Psychiatry ; 8(12): 1030-1031, 2021 12.
Article in En | MEDLINE | ID: mdl-34801117
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / COVID-19 Limits: Humans Language: En Journal: Lancet Psychiatry Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / COVID-19 Limits: Humans Language: En Journal: Lancet Psychiatry Year: 2021 Document type: Article